Quest Diagnostics has promoted Tracy Cinco-Abela to be VP and treasurer. Before Cinco-Abela joined Quest in 2007 she worked for the General Motors treasurer's office, and at Quest she most recently was the company's assistant treasurer.
Pressure BioSciences has appointed Mickey Urdea to serve on its board of directors, filling the seat left by Wayne Fritzsche, who resigned last week to pursue a full-time management position at the company.
Urdea, who also will lead PBI's scientific advisory board, founded and is a managing partner of the biotech consulting firm Halteres Associates. He also founded and was CEO of Tethys Bioscience, and he helped found and served as chairman of the Catalysis Foundation for Health.
Nanosphere said this week in its fourth-quarter financial report that it has promoted Michael McGarrity to succeed William Moffitt as its new president and CEO.
The company also said it has appointed Sheli Rosenberg, Michael Ward, and McGarrity to serve on its board of directors, while Moffitt, William White, Mark Slezak, and Roy Davis have all resigned from the board. Rosenberg, who served on Nanosphere's board from 2002 to 2012, will be the new chair of the board.
McGarrity previously was VP of sales and marketing and chief commercial officer, and he has 24 years of experience in the medical devices industry, including 13 years at Stryker.
Danaher said in a filing with the Securities and Exchange Commission that Mortimer Caplin has decided not to stand for reelection to the company's board of directors and will retire after the firm's annual meeting in May.